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As the rates of cesarean delivery increase, there has been a
proportional increase in the rates of placenta accreta.1 Clini-
cally, placenta accreta is deﬁned by placental invasion of the
uterine wall or an inability to separate the placenta from the
uterine wall at the time of delivery.2 Pathologically, placenta
accreta, increta, and percreta are diagnosedwhen theplacenta
extends through the decidua basalis and into themyometrium
or uterine serosa, respectively.3 Patients with placenta accreta
are at ahigh riskofmaternalmorbidityormortalityat the time
of delivery and usually require cesarean hysterectomy.3
However, even despite advances in imaging and greater
understanding of risk factors, rates of preoperative diagnosis
of placenta accreta remain low, 30 to 80%, depending on the
practice setting and country, with a recent rate of 50%
reported from a large United States database.4 This means
that obstetrician–gynecologists are oftenmaking split-second
decisions regarding the need for the morbid and sterilizing
procedure of hysterectomy.5–7 Further research is needed
to understand the accuracy and consequences of these
decisions.5,8–14
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Abstract Objective To investigate the association between the intraoperative diagnosis of
placenta accreta at the time of cesarean hysterectomy and pathological diagnosis.
Study Design This is a retrospective cohort study of all patients undergoing cesarean
hysterectomy for suspected placenta accreta from 2000 to 2016 at Barnes-Jewish
Hospital. The primary outcome was the presence of invasive placentation on the
pathology report. We estimated predictive characteristics of clinical diagnosis of
placenta accreta using pathological diagnosis as the correct diagnosis.
Results There were 50 cesarean hysterectomies performed for suspected abnormal
placentation from 2000 to 2016. Of these, 34 (68%) had a diagnosis of accreta
preoperatively and 16 (32%) were diagnosed intraoperatively at the time of cesarean
delivery. Two patients had no pathological evidence of invasion, corresponding to a
false-positive rate of 4% (95% conﬁdence interval [CI]: 0.5%, 13.8%) and a positive
predictive value of 96% (95% CI: 86.3%, 99.5%). There were no differences in
complications among patients diagnosed intraoperatively compared with those
diagnosed preoperatively.
Conclusion Most patients undergoing cesarean hysterectomy for placenta accreta do
have this diagnosis conﬁrmed on pathology. However, since the diagnosis of placenta
accreta was made intraoperatively in nearly a third of cesarean hysterectomies,
intraoperative vigilance is required as the need for cesarean hysterectomy may not
be anticipated preoperatively.
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Therefore, the objectives of this study were to (1) inves-
tigate the relative frequency of preoperative versus intrao-
perative diagnosis of placenta accreta, (2) investigate the
association between the diagnosis of placenta accreta at the
time of cesarean hysterectomy and pathological diagnosis,
and (3) test the hypothesis that compared with intraopera-
tive diagnosis, preoperative diagnosis of placenta accreta is
associated with a lower risk of intraoperative complications.
Materials and Methods
This is a retrospective cohort study of patients undergoing
cesarean hysterectomy for suspected placenta accreta. All
patients undergoing cesarean hysterectomy from 2000 to
2016 at Washington University School of Medicine in St.
Louis for suspected placenta accreta were included. Placenta
accreta was deﬁned as placental invasion to (accreta), into
(increta), or through (percreta) the myometrial wall.2
Patients were identiﬁed by searching the comprehensive
billing database for relevant ICD-9 (International Statistical
Classiﬁcation of Diseases and Related Health Problems) and
CPT (Current Procedural Terminology) codes capturing hys-
terectomy at the time of cesarean and placenta accreta.
Patients were excluded if they underwent cesarean hyster-
ectomy for other indications (e.g., uterine rupture, atony) or
if placenta pathology reports were unavailable. The electro-
nicmedical records of all eligible patientswere reviewed.We
abstracted patient and pregnancy characteristics including
preoperative diagnoses, imaging studies when available,
intraoperative ﬁndings, and placental pathology results.
The operative report (speciﬁcally the listed preoperative
diagnosis, postoperative diagnosis, and operative ﬁndings)
was used to determine the preoperative diagnosis as well as
the intraoperative ﬁndings. In cases of ambiguity, the report
was reviewed by multiple authors to achieve consensus.
We deﬁned “clinical diagnosis” as any nonpathological
diagnosis (made either preoperatively or intraoperatively),
“preoperative diagnosis” as having placenta accreta listed as
a preoperative diagnosis on the operative report or included in
the indications for procedure, and “intraoperative diagnosis”
asaclinicaldiagnosisﬁrstmadeat thetimeofcesareansection.
Patient and pregnancy information included maternal age,
gestational age at delivery, race, height andweight at the time
of delivery, obstetric history, number of prior cesarean deliv-
eries, multiple pregnancies, tobacco use, and presence of
placenta previa. Gestational age was based on the best obste-
trical estimate as recorded in the medical record. All types of
placenta previa (marginal, complete, etc.) were categorized as
placenta previa. Imaging data included ultrasound and, in
somecases,magnetic resonance imaging (MRI) reports. Patho-
logical diagnoseswere determined from the pathology report.
Incasesofmultiple levelsof invasion, themost severewasused
(e.g., “placenta accreta with focal increta” was coded as
“increta”). Surgical ﬁndings and complications were based
on the operative report. The type of surgery was categorized
as either cesarean total hysterectomy or cesarean supracervi-
cal hysterectomy. Intraoperative complications were categor-
ized as cystotomy, ureteral injury, or other. Intentional
cystotomies were recorded as “cystotomy.” Admission to the
intensive care unit was noted. Estimated blood loss was
obtained from the operative report. Intraoperative blood
transfusion of packed red blood cells was recorded in units
based on the operative report and anesthesia record.
The primary outcome was the diagnosis of invasive pla-
centation in the pathology report. Secondary outcomes were
estimated blood loss and intraoperative complications. Test
characteristics including positive predictive value and false-
positive rate with 95% conﬁdence intervals (CIs) of clinical
diagnosis were estimated with the pathology diagnosis of
placenta accreta as the gold standard. Patients were categor-
ized into two groups based on the timing of diagnosis of
placenta accreta: preoperative or intraoperative, as dis-
cussed previously. Baseline characteristics and outcome
measures were compared with the Mann–Whitney U-test
or Fisher’s exact test as appropriate.
Study data were collected and managed using REDCap
electronic data capture tools hosted at the Washington
University School of Medicine in St. Louis.15 The study was
approved by the Washington University in St. Louis Human
Research Protection Ofﬁce. Given that we included all women
who met inclusion criteria and the sample size was ﬁxed, we
did not perform an a priori sample size calculation. Analyses
wereperformed inSASsoftware (version9.2, SAS Institute Inc.,
Cary, NC). A p-value of <0.05 was considered statistically
signiﬁcant. We did not adjust for multiple comparisons.
Results
From 2000 to 2016, 80 cesarean hysterectomies were per-
formed: 52 of which were for suspected placenta accreta (2
had a missing pathology report, leaving a ﬁnal sample size of
50) (►Fig. 1). Themajorityof thesewere in theyears from2013
to 2016 (n ¼ 28), with the remainder distributed relatively
evenly over the preceding years. Of the 50 patients, 34 (68%)
had a preoperative diagnosis of placenta accreta, whereas the
diagnosis was ﬁrst made intraoperatively in the remaining 16
(32%) at the time of cesarean delivery. Themajority of patients
(n ¼ 38; 76%) had a preoperative diagnosis of placenta previa
and at least one prior cesarean delivery.
Baseline characteristics were similar among patients
diagnosed preoperatively and intraoperatively, with the
notable exception that placenta previa and prior cesarean
were more common among patients diagnosed preopera-
tively: placenta previa (97 vs. 44%; p < 0.0001) and mean
number of prior cesareans (3 vs. 2; p ¼ 0.02) (►Table 1).
In all, 48 (96%) patients had conﬁrmed placenta accreta in
the pathology report, whereas 2 (4%) patients had no evidence
of invasion. This corresponds to an overall positive predictive
value of a clinical diagnosis of 96% (95%CI: 86.3%, 99.5%), and a
false-positive rate of 4% (95% CI: 0.5%, 13.8%) (►Table 2).
Of the 16 patients with initial intraoperative diagnosis, 9
(56%) had an initial attempt to remove the placenta. The
remainderdidnothavesuchanattemptdue tovisiblyabnormal
placentation at the time of the delivery. All patients who were
ﬁrst diagnosed intraoperatively (n ¼ 16) had pathological con-
ﬁrmation of placenta accreta.
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Fig. 1 Study ﬂow diagram.
Table 1 Preoperative characteristics (n ¼ 50)
Characteristic Entire cohort
(n ¼ 50)
Invasion diagnosed
preoperatively
(n ¼ 34)
Invasion first diagnosed
intraoperatively
(n ¼ 16)
p-Valuea
Maternal age, years 31.4 (5.9) 31.7 (5.3) 30.8 (7.2) 0.44
Gestational age at delivery, weeks 33 (3.1) 33.4 (3.2) 32.3 (3.8) 0.24
Race 0.72
Black 17 (34) 10 (29) 7 (44)
Caucasian 29 (58) 21 (62) 8 (50)
Other 4 (8) 3 (9) 1 (6)
Body mass index (kg/m2) 31.5 (7.3) 31.3 (8.2) 31.9 (5.1) 0.44
Gravidity 5 (2) 5 (2) 4 (1) 0.04
Parity 3 (2) 3 (2) 2 (1) 0.16
Prior cesarean delivery 46 (94) 32 (94) 14 (88) 0.58
Number of prior cesareans 2 (1) 3 (2) 2 (1) 0.02
Multiple pregnancy 4 (8) 1 (3) 3 (18) 0.09
Tobacco use 8 (16) 6 (18) 2 (13) 1
Placenta previa 40 (80) 33 (97) 7 (44) <0.0001
aValues using Mann–Whitney U-test or Fisher’s exact test.
Note: Data are presented as n (%) or mean (standard deviation).
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►Table 3 shows the relationship between intraoperative
diagnosis of the degree of abnormality and the pathological
diagnosis. Of the two false-positive clinical diagnoses of pla-
cental invasion, onewas thought to be a placenta accretawhile
the otherwas a suspectedplacenta increta. Bothpatientshada
preoperative ultrasound diagnosis of placenta accreta.
Most patients (84%) had total cesarean hysterectomy, and
the remainder (16%) had supracervical hysterectomy. There
was no difference in total hysterectomy rates in patientswith
preoperative and postoperative diagnoses of placenta
accreta (88 vs. 75%; p ¼ 0.25). The median blood loss was
2,500 mL for the entire cohort, with mean hospital length of
stay of 4.5 days, with no differences between the groups
diagnosed preoperatively versus intraoperatively. Nearly one
in ﬁve womenwere admitted to the intensive care unit, with
no differences in those diagnosed preoperatively and intrao-
peratively (21 vs. 13%; p ¼ 0.70) (►Table 4). There were no
maternal deaths. Intraoperative surgical injury was com-
mon, with nearly one in three patients sustaining a cystost-
omy, ureteral injury, or other type of injury (n ¼ 16; 32%).
Discussion
We found that nearly one-third of diagnoses of placenta
accreta were only made at the time of delivery. Addition-
ally, although overall clinical diagnosis (preoperative and
intraoperative) was largely accurate, there was a 4% false-
positive rate where the clinical diagnosis of placenta
accreta was not conﬁrmed on pathological examination.
There were no signiﬁcant differences in outcomes between
patients diagnosed preoperatively and those diagnosed
intraoperatively.
These ﬁndings indicate that when faced with a “surprise”
potential placenta accreta, clinical diagnosis is highly accu-
rate. The majority of the 16 patients with initial intraopera-
tive diagnosis had an initial attempt to remove the placenta,
suggesting that the diagnosis was indeed unexpected. Nota-
bly, all of these patients had pathological conﬁrmation of
Table 2 Pathological outcomes (n ¼ 50)
Outcome n (%)
No invasion 2 (4)
Accreta 19 (38)
Increta 18 (36)
Percreta 11 (22)
Table 3 Relationship between intraoperative and pathological diagnoses (n ¼ 50)
Pathological diagnosis
Intraoperative diagnosis No invasion Accreta Increta Percreta
Accreta 1 (2) 14 (28) 13 (26) 4 (8)
Increta 1 (2) 1 (2) 3 (6) 2 (4)
Percreta 0 (0) 4 (8) 2 (4) 5 (10)
Table 4 Surgical outcomes (n ¼ 50)
Outcome Entire cohort Invasion diagnosed
preoperatively
(n ¼ 34)
Invasion diagnosed
intraoperatively
(n ¼ 16)
p-Value
Surgical procedure 0.25
Cesarean total hysterectomy 42 (84) 30 (88) 12 (75)
Cesarean supracervical
hysterectomy
8 (16) 4 (12) 4 (25)
Intraoperative complication 16 (32) 14 (41) 2 (12) 0.26
Cystotomy 13 (26) 11(32) 2 (13)
Ureteral injury 1 (2) 1 (3) 0 (0)
Other 2 (4) 2 (6) 0 (0)
Intensive care unit admission 9 (18) 7 (21) 2 (13) 0.70
Estimated blood loss (mL) 2,400 (1,500–3,100) 2,600 (1,500–3,500) 2,000 (1,250–2,750) 0.13
Packed red blood cells transfused
intraoperatively (units)
2.5 (1–4) 3 (1–5) 2 (0.5–4) 0.37
Length of postoperative admission,
days, mean (standard deviation)
4.5 (1.2) 4.7 (1.4) 4.1 (0.6) 0.22
Note: Data are presented as n (%) or median (interquartile range). p-Values derived using Mann–Whitney U-test or Fisher’s exact test comparing
preoperative and intraoperative diagnosis groups.
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placenta accreta, further suggesting that the abandonment
of the placenta delivery attempt and the decision to perform
hysterectomy was justiﬁed.
The proportion of intraoperative versus preoperative
diagnosis of placenta accreta in our study were similar to
those in other studies, which have ranged from a preopera-
tive diagnosis rate of 30 to 80%.5,6,10,14,16 In a retrospective
case series of 99 pathologically conﬁrmed placenta accreta
cases, 63% were diagnosed antepartum and the remaining
37% diagnosed at delivery.14 On the other hand, in a recent
study of 205 cases from the Nordic countries, 70% were
undiagnosed preoperatively.5 However, that study consid-
ered only clinical diagnosis and not pathological diagnosis. In
our study, patients with risk factors were more likely to be
diagnosed preoperatively, perhaps reﬂecting provider bias in
more vigilantly searching for placenta accreta in patients
with risk factors.
Further study is needed to improve rates of preoperative
diagnosis.17 The diagnostic accuracy of ultrasound for abnor-
mal placentation is variable, with a recent report citing a
false-negative rate as high as 16%.10 However, a meta-ana-
lysis noted that in experienced units, ultrasound is highly
sensitive and speciﬁc for the diagnosis of placenta accreta
with prenatal detection rates of >90%.11 This variability in
the accuracy of ultrasound diagnosis of abnormal placenta-
tion is likely because of the operator–dependent nature of
ultrasound examinations.
It is recognized that patients with placenta accreta have
better outcomes when treated in a specialty center with
multidisciplinary care.7–9 However, it is unclear to
what degree the patients managed by regular care in these
studies had a suspected diagnosis prior to surgery.8 Notably,
a recent study from across the United States actually found
worse outcomes in patients with a preoperative diagnosis
compared with an initial intraoperative diagnosis, perhaps
due to more severe disease.4 The lack of signiﬁcant differ-
ences in outcomes between patients with preoperative
diagnosis and those with intraoperative diagnosis in our
study may be attributable to the fact that patients were
treated in a regional perinatal health care center with con-
tinuous access to advanced pelvic surgeons as well as robust
intensive care and blood bank services.18 Thus, outcomes
may not be the same as in a community setting where an
unplanned cesarean hysterectomy confers signiﬁcantlymore
morbidity.9
There were several strengths of our study. The study was
conducted in an institution with common approaches to the
diagnosis and management of placenta accreta. In addition,
detailed data were abstracted, allowing for comprehensive
analysis.However, there are limitations tobe consideredwhen
interpreting our results. This is a retrospective cohort study
based on chart review of patients identiﬁed through billing
codes. While we used exhaustive codes to in an attempt to
identify all patients meeting the inclusion criteria, there is a
possibility that some patients were missed. Moreover, accu-
racy of the distinction between preoperative and intraopera-
tive diagnosis of placenta was based on the listed diagnoses
and descriptions in the operative reports, which may reﬂect
provider bias. Although our sample size is comparable to prior
studies, it is relatively small andmayhave impacted our ability
toﬁnd statistically signiﬁcant differences.1,14,16 Finally,wedid
nothave informationaboutpreoperativediagnosesofplacenta
accreta that were not clinically corroborated intraoperatively
and therefore did not lead to cesarean hysterectomy. This
made it impossible to estimate the test characteristics of
preoperative imaging and diagnosis.
In conclusion, in our cohort, the diagnosis of placenta
accreta was ﬁrst made intraoperatively in nearly a third of
cesarean hysterectomies. While most patients undergoing
cesarean hysterectomy for clinically diagnosed placenta
accreta had the diagnosis conﬁrmed on pathological exam-
ination, therewas a 4% false-positive rate.When facedwith a
clinical situation concerning for placenta accreta, clinicians
can be reassured that clinical diagnosis is highly accurate.
These ﬁndings reinforce the need for vigilance intraopera-
tively as the need for cesarean hysterectomy may not be
anticipated preoperatively. As summarized in a recent edi-
torial by Nageotte, clinicians must remain alert and ready for
the potential for an undiagnosed placenta accreta at all
times.19
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